{"name": "Catabasis Pharmaceuticals",
 "permalink": "catabasis-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/catabasis-pharmaceuticals",
 "homepage_url": "http://www.catabasispharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2008,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@catabasispharma.com",
 "phone_number": "617-349-1971",
 "description": "",
 "created_at": "Wed Jan 20 08:19:55 UTC 2010",
 "updated_at": "Sun Mar 24 10:47:13 UTC 2013",
 "overview": "\u003Cp\u003ECatabasis Pharmaceuticals, Inc. is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. There platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of novel mechanism of action therapies to safely and effectively treat inflammatory diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       37],
      "assets/images/resized/0010/6512/106512v1-max-150x150.png"],
     [[250,
       62],
      "assets/images/resized/0010/6512/106512v1-max-250x250.png"],
     [[398,
       99],
      "assets/images/resized/0010/6512/106512v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jill",
      "last_name": "C. Milne",
      "permalink": "jill-c-milne",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Product Development",
    "person":
     {"first_name": "Michael",
      "last_name": "Curtis",
      "permalink": "michael-curtis",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$72.6M",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.masshightech.com/stories/2010/01/18/daily3-Catabasis-Pharma-pulls-in-2M.html",
    "source_description": "Catabasis Pharma pulls in $2M",
    "raised_amount": 2000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 18,
    "investments":
     []},
   {"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/catabasis-nails-39m-series-diabetes-programs/2010-04-21",
    "source_description": "Catabasis lands $39M Series A for diabetes programs",
    "raised_amount": 39000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MedImmune Ventures",
         "permalink": "medimmune-ventures",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0004/9449/49449v2-max-150x150.jpg"],
             [[250,
               31],
              "assets/images/resized/0004/9449/49449v2-max-250x250.jpg"],
             [[450,
               57],
              "assets/images/resized/0004/9449/49449v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advanced Technology Ventures",
         "permalink": "advanced-technology-ventures",
         "image":
          {"available_sizes":
            [[[150,
               76],
              "assets/images/resized/0002/1155/21155v2-max-150x150.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-250x250.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/catabasis-lands-145m-tranche-omega-3-drug-development/2010-12-08?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Catabasis lands $14.5M tranche for Omega-3 drug development",
    "raised_amount": 14500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 12,
    "funded_day": 8,
    "investments":
     []},
   {"round_code": "a",
    "source_url": "http://www.catabasispharma.com/pdfs/Catabasis_Final_Financing_PR_12.13.11.pdf",
    "source_description": "Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MedImmune Ventures",
         "permalink": "medimmune-ventures",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0004/9449/49449v2-max-150x150.jpg"],
             [[250,
               31],
              "assets/images/resized/0004/9449/49449v2-max-250x250.jpg"],
             [[450,
               57],
              "assets/images/resized/0004/9449/49449v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advanced Technology Ventures",
         "permalink": "advanced-technology-ventures",
         "image":
          {"available_sizes":
            [[[150,
               76],
              "assets/images/resized/0002/1155/21155v2-max-150x150.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-250x250.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "http://www.masshightech.com/stories/2012/04/02/daily31-Catabasis-gets-120K-from-MDA-to-test-compounds.html",
    "source_description": "Catabasis gets $120K from MDA to test compounds",
    "raised_amount": 120000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 4,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/catabasis-raises-9m-phii-ready-drug-development-program/2013-02-06?utm_source=rss\u0026utm_medium=rss",
    "source_description": "Catabasis raises $9M for PhII-ready drug development program",
    "raised_amount": 9000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 2,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MedImmune Ventures",
         "permalink": "medimmune-ventures",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0004/9449/49449v2-max-150x150.jpg"],
             [[250,
               31],
              "assets/images/resized/0004/9449/49449v2-max-250x250.jpg"],
             [[450,
               57],
              "assets/images/resized/0004/9449/49449v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advanced Technology Ventures",
         "permalink": "advanced-technology-ventures",
         "image":
          {"available_sizes":
            [[[150,
               76],
              "assets/images/resized/0002/1155/21155v2-max-150x150.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-250x250.png"],
             [[163,
               83],
              "assets/images/resized/0002/1155/21155v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "19 Blackstone Street",
    "address2": "",
    "zip_code": "02139",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/4060/74060v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/4060/74060v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/4060/74060v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}